Topadur Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Topadur Pharma's estimated annual revenue is currently $2.3M per year.
- Topadur Pharma's estimated revenue per employee is $155,000
Employee Data
- Topadur Pharma has 15 Employees.
- Topadur Pharma grew their employee count by 0% last year.
Topadur Pharma's People
| Name | Title | Email/Phone |
|---|
Topadur Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Topadur Pharma?
TOPADUR Pharma AG is a Swiss biopharmaceutical start-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R&D Pharma. TOPADUR's vision is to improve patients' quality of life by providing highly effective and safe drugs for unmet medical conditions. TOPADUR has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases like chronic wounds, skin fibrosis, glaucoma, colorectal cancer, hair loss and skin aging.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Topadur Pharma News
... NicOx SA, SynZyme Technologies LLC, Topadur Pharma AG ... Bayer AG; Boehringer Ingelheim GmbH; Ironwood Pharmaceuticals Inc; NicOx SA...
Other Companies in Schlieren
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 28 | 4% | N/A |
#2 | $5M | 32 | 10% | N/A |
#3 | $3.9M | 34 | N/A | N/A |
#4 | $5.4M | 35 | -8% | N/A |
#5 | $4M | 36 | N/A | N/A |